GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Sanjiu Medical & Pharmaceutical Co Ltd (SZSE:000999) » Definitions » Cyclically Adjusted FCF per Share

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Cyclically Adjusted FCF per Share : ¥1.66 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is China Resourcesnjiu Medical & Pharmaceutical Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

China Resourcesnjiu Medical & Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥0.680. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥1.66 for the trailing ten years ended in Mar. 2024.

During the past 12 months, China Resourcesnjiu Medical & Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 21.20% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.20% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of China Resourcesnjiu Medical & Pharmaceutical Co was 66.30% per year. The lowest was 7.50% per year. And the median was 13.95% per year.

As of today (2024-06-07), China Resourcesnjiu Medical & Pharmaceutical Co's current stock price is ¥64.65. China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥1.66. China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 38.95.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China Resourcesnjiu Medical & Pharmaceutical Co was 123.33. The lowest was 18.93. And the median was 33.19.


China Resourcesnjiu Medical & Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resourcesnjiu Medical & Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

China Resourcesnjiu Medical & Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.09 1.18 1.23 1.38 1.58

China Resourcesnjiu Medical & Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.45 1.54 1.58 1.66

Competitive Comparison of China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



China Resourcesnjiu Medical & Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, China Resourcesnjiu Medical & Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.68/115.2271*115.2271
=0.680

Current CPI (Mar. 2024) = 115.2271.

China Resourcesnjiu Medical & Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.367 98.200 0.431
201409 0.167 98.900 0.195
201412 0.325 99.000 0.378
201503 0.020 99.900 0.023
201506 0.484 99.500 0.561
201509 0.196 100.500 0.225
201512 0.248 100.600 0.284
201603 0.107 102.200 0.121
201606 0.458 101.400 0.520
201609 0.208 102.400 0.234
201612 0.282 102.600 0.317
201703 0.074 103.200 0.083
201706 0.562 103.100 0.628
201709 0.328 104.100 0.363
201712 0.290 104.500 0.320
201803 0.139 105.300 0.152
201806 0.663 104.900 0.728
201809 0.289 106.600 0.312
201812 0.238 106.500 0.258
201903 0.226 107.700 0.242
201906 0.791 107.700 0.846
201909 0.217 109.800 0.228
201912 0.205 111.200 0.212
202003 0.560 112.300 0.575
202006 0.242 110.400 0.253
202009 0.362 111.700 0.373
202012 0.462 111.500 0.477
202103 0.063 112.662 0.064
202106 0.626 111.769 0.645
202109 0.170 112.215 0.175
202112 0.176 113.108 0.179
202203 0.311 114.335 0.313
202206 1.295 114.558 1.303
202209 -0.155 115.339 -0.155
202212 0.623 115.116 0.624
202303 0.106 115.116 0.106
202306 1.309 114.558 1.317
202309 1.074 115.339 1.073
202312 0.911 114.781 0.915
202403 0.680 115.227 0.680

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


China Resourcesnjiu Medical & Pharmaceutical Co  (SZSE:000999) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=64.65/1.66
=38.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of China Resourcesnjiu Medical & Pharmaceutical Co was 123.33. The lowest was 18.93. And the median was 33.19.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


China Resourcesnjiu Medical & Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of China Resourcesnjiu Medical & Pharmaceutical Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Business Description

Traded in Other Exchanges
N/A
Address
High-Tech Park, Lake Street Mission Hills, Longhua District, Shenzhen, CHN, 518110
China Resources Sanjiu Medical & Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in the research and development, production and sale of pharmaceutical products, healthcare products, and medical appliances under the brand name 999, which includes OTC, antibiotic and raw material drug. The other brands under which the company offers its products are Lee King, Shunfeng, and Tianhe. The company's core business is located in OTC and Chinese medicine prescription drugs, OTC core products in the cold, gastrointestinal, skin, pediatric, cough and orthopedic drugs occupy a higher market share; prescription drug products in traditional Chinese medicine formula granules, cardiovascular and cerebrovascular, anti-tumor in the field of anti-infection and other areas.
Executives
Yang Zhan Ao Executives
Independent director
Li De Ming Supervisors
Lin Xi Ping Supervisors
Fang Ming Director
Mai Yi Executives

China Resourcesnjiu Medical & Pharmaceutical Co (SZSE:000999) Headlines

No Headlines